Table 2.
CD3+ (%) | CD3+ CD4+ (%) | CD3+ CD8+ (%) | CD19+ (%) | |
---|---|---|---|---|
Control | 9.4 (2.4–45.8) | 48.0 (44.0–49.5) | 46.2 (43.4–50.9) | 6.6 (3.1–9.9) |
Nose-only | 22.5 (16.0–33.3) | 48.9 (45.2–50.3) | 47.6 (45.8–48.9) | 11.9 (5.6–14.8) |
Whole-body | 47.8 (33.5–62.2) (**) ($) | 47.8 (46.2–51.0) | 48.0 (42.4–49.6) | 15.7 (10.1–20.1) (*) |
Data are expressed as median (Q1-Q3) (n = 8–15)
Lymphocytes were characterized with flow cytometry for respective T-lymphocytes (CD3+), T-helper (CD3+ CD4+), Cytotoxic T cell (CD3+ CD8+) and B-cell (CD19+) populations
*p < 0.05; **p < 0.01 for control vs. whole-body and $p < 0.05 for nose-only vs. whole-body